Supplement Brands Touch Skin. Regulators Notice. Classification Is Everything.
Dietary supplement companies expanding into wearables and connected wellness products now face FDA and CPSC scrutiny they did not previously encounter. Any wearable contacting skin must be assessed for toxicity, and specific warnings or labeling may be required if the device could irritate or inflame skin. Regulators will focus on a familiar question: what is the product's intended use, and how does that affect its regulatory classification.
The underlying principle is regulatory perimeter expansion. The mechanism is intended-use classification. When a supplement company adds a wearable, it is no longer just a supplement company. It has crossed into a product category governed by different statutes. The intended use of the device, not the brand's identity, determines which agency applies and which rules bind.
The analysis comes from NutraIngredients, covering dietary supplement companies entering the wearables and connected wellness product market as of August 2026.
- Go to fda.gov and search for 'intended use' guidance to understand how the FDA determines whether a product is a cosmetic, supplement, or medical device.
- Pick any wearable wellness product you own and write down every claim on its packaging.
- Sort each claim into 'structure function' versus 'disease treatment' categories. The moment you write 'treats,' you have changed your regulatory classification. That is the entire lesson.